Risk factors for complications after surgery for pancreatic neuroendocrine tumors
Author:
van Beek Dirk-JanORCID, Takkenkamp Tim J., Wong-Lun-Hing Edgar M., de Kleine Ruben H.J., Walenkamp Annemiek M.E., Klaase Joost M., Nijkamp Maarten W.ORCID, Valk Gerlof D.ORCID, Molenaar I. Quintus, Hagendoorn Jeroen, van Santvoort Hjalmar C., Borel Rinkes Inne H.M., Hoogwater Frederik J.H., Vriens Menno R.
Reference51 articles.
1. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States;Dasari;JAMA Oncol,2017 2. Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: experience of two decades of cancer registry;Korse;Eur J Cancer,2013 3. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival;Halfdanarson;Ann Oncol,2008 4. Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit;van Rijssen;HPB (Oxford),2017 5. Transatlantic registries of pancreatic surgery in the United States of America, Germany, the Netherlands, and Sweden: comparing design, variables, patients, treatment strategies, and outcomes;Mackay;Surgery,2020
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|